sever
acut
respiratori
syndrom
viru
sarscov
caus
agent
sar
outbreak
safer
vitro
system
desir
conduct
research
sarscov
screen
antivir
drug
viru
base
infecti
cdna
clone
rsarscovd
e
gene
delet
safe
noninfecti
replicon
construct
replac
gene
enhanc
green
fluoresc
protein
egfp
gene
success
replic
achiev
evid
continu
express
egfp
detect
fluoresc
western
blot
treatment
antivir
drug
demonstr
replic
could
significantli
inhibit
mgml
cystein
proteinas
inhibitor
ribavirin
replicon
contain
delet
code
region
nonstructur
protein
nsp
confirm
previou
observ
essenti
effici
viral
replic
transcript
elsevi
inc
right
reserv
sever
acut
respiratori
syndrom
sar
ill
caus
novel
coronaviru
sarscov
first
aros
guangdong
provinc
china
late
viru
spread
rapidli
countri
kill
peopl
infect
patient
fatal
rate
though
sar
epidem
final
control
patient
isol
ban
wild
anim
trade
signific
morbid
mortal
especi
potenti
threat
sar
reemerg
remind
us
continu
risk
face
public
health
system
moreov
wide
distribut
genet
divers
sarslik
cov
discov
china
also
serv
warn
potenti
human
infect
relat
batborn
cov
sarscov
resembl
member
three
previous
known
group
coronaviru
classifi
member
group
famili
coronavirida
base
phylogenet
analysi
genom
sequenc
sarscov
virion
contain
singlestrand
rna
genom
posit
polar
first
twothird
genom
encod
two
overlap
polyprotein
like
coronavirus
two
polyprotein
process
matur
replicas
protein
viral
specif
proteinas
believ
associ
poorli
character
replicationtranscript
complex
mediat
synthesi
genom
rna
replic
subgenom
mrna
transcript
recent
function
sever
nonstructur
protein
nsp
determin
includ
noncanon
rdrp
singlestrand
rnabind
protein
rnadepend
rna
polymeras
superfamili
helicas
exonucleas
uridylatespecif
endoribonucleas
oribos
methyltransferas
activ
complic
interact
network
among
nsp
make
difficult
imposs
fulli
understand
function
rest
end
genom
code
four
main
structur
protein
spike
envelop
e
membran
nucleocapsid
n
protein
protein
mediat
cell
attach
membran
fusion
respons
viru
host
rang
tissu
tropism
protein
e
n
assembl
noninfecti
viru
like
particl
vlp
absenc
besid
nsp
major
structur
protein
sarscov
possess
sever
groupspecif
protein
function
viru
life
cycl
remain
elus
delet
gene
protein
seem
effect
viru
replic
andor
transcript
recent
studi
groupspecif
protein
reveal
may
associ
viru
pathogenesi
virushost
interact
sarscov
highli
virul
classifi
biosafeti
level
agent
handl
laboratori
indepth
studi
function
differ
viral
protein
regulatori
sequenc
element
revers
genet
fulllength
infecti
cdna
clone
establish
use
variou
techniqu
includ
bacteri
artifici
chromosom
bac
vector
sarscov
replicon
cell
line
also
use
antivir
drug
screen
among
sarscov
replicon
cell
line
retain
gene
necessari
replic
see
front
matter
sever
acut
respiratori
syndrom
viru
sarscov
caus
agent
sar
outbreak
safer
vitro
system
desir
conduct
research
sarscov
screen
antivir
drug
viru
base
infecti
cdna
clone
rsarscovd
e
gene
delet
safe
noninfecti
replicon
construct
replac
gene
enhanc
green
fluoresc
protein
egfp
gene
success
replic
achiev
evid
continu
express
egfp
detect
fluoresc
western
blot
treatment
antivir
drug
demonstr
replic
could
significantli
inhibit
mgml
cystein
proteinas
inhibitor
ribavirin
replicon
contain
delet
code
region
nonstructur
protein
nsp
confirm
previou
observ
essenti
effici
viral
replic
transcript
elsevi
inc
right
reserv
sever
acut
respiratori
syndrom
sar
ill
caus
novel
coronaviru
sarscov
first
aros
guangdong
provinc
china
late
viru
spread
rapidli
countri
kill
peopl
infect
patient
fatal
rate
though
sar
epidem
final
control
patient
isol
ban
wild
anim
trade
signific
morbid
mortal
especi
potenti
threat
sar
reemerg
remind
us
continu
risk
face
public
health
system
moreov
wide
distribut
genet
divers
sarslik
cov
discov
china
also
serv
warn
potenti
human
infect
relat
batborn
cov
sarscov
resembl
member
three
previous
known
group
coronaviru
classifi
member
group
famili
coronavirida
base
phylogenet
analysi
genom
sequenc
sarscov
virion
contain
singlestrand
rna
genom
posit
polar
first
twothird
genom
encod
two
overlap
polyprotein
like
coronavirus
two
polyprotein
process
matur
replicas
protein
viral
specif
proteinas
believ
associ
poorli
character
replicationtranscript
complex
mediat
synthesi
genom
rna
replic
subgenom
mrna
transcript
recent
function
sever
nonstructur
protein
nsp
determin
includ
noncanon
rdrp
singlestrand
rnabind
protein
rnadepend
rna
polymeras
superfamili
helicas
exonucleas
uridylatespecif
endoribonucleas
oribos
methyltransferas
activ
complic
interact
network
among
nsp
make
difficult
imposs
fulli
understand
function
rest
end
genom
code
four
main
structur
protein
spike
envelop
e
membran
nucleocapsid
n
protein
protein
mediat
cell
attach
membran
fusion
respons
viru
host
rang
tissu
tropism
protein
e
n
assembl
noninfecti
viru
like
particl
vlp
absenc
besid
nsp
major
structur
protein
sarscov
possess
sever
groupspecif
protein
function
viru
life
cycl
remain
elus
delet
gene
protein
seem
effect
viru
replic
andor
transcript
recent
studi
groupspecif
protein
reveal
may
associ
viru
pathogenesi
virushost
interact
sarscov
highli
virul
classifi
biosafeti
level
agent
handl
laboratori
indepth
studi
function
differ
viral
protein
regulatori
sequenc
element
revers
genet
fulllength
infecti
cdna
clone
establish
use
variou
techniqu
includ
bacteri
artifici
chromosom
bac
vector
sarscov
replicon
cell
line
also
use
antivir
drug
screen
among
sarscov
replicon
cell
line
retain
gene
necessari
replic
transcript
repres
safest
system
avail
howev
cell
line
need
continu
select
antibiot
readili
amen
introduct
mutat
differ
protein
code
gene
report
construct
plasmidbas
replicon
system
introduc
cell
transfect
easili
manipul
introduct
mutat
use
replicon
demonstr
applic
test
known
antivir
drug
confirm
essenti
function
viru
replic
cell
virus
cell
line
use
studi
maintain
dmem
medium
gibco
supplement
volvol
foetal
bovin
serum
fb
gibco
plasmid
rsarscovd
encod
infecti
attenu
viru
deriv
sarscov
urbani
strain
genbank
access
kindli
provid
dr
lui
enjuan
cnb
csic
madrid
pcr
amplif
egfp
gene
modif
pbluescriptii
primer
egfpf
egfpr
spei
site
underlin
use
amplifi
egfp
gene
vector
clontech
pcr
product
purifi
agaros
gel
clone
pgemt
easi
vector
promega
sequenc
authent
clone
mutat
use
subsequ
clone
plasmid
pbluescriptii
clontech
modifi
insert
bp
sequenc
tatggtaccgtttaaacgacggatcctctagac
contain
polyclon
site
use
vector
site
kpni
xbai
underlin
result
introduct
pmei
gtttaaac
site
delet
spei
origin
vector
construct
replicon
pbacsarscovdedsegfp
previous
construct
infecti
cdna
clone
plasmid
rsarscovd
digest
pmei
bamhi
produc
kb
fragment
contain
end
gene
fragment
subclon
modifi
pbluescriptii
vector
describ
gener
plasmid
egfp
gene
insert
replac
gene
singl
enzym
spei
gener
gfp
contain
fragment
clone
back
pbacsarscovd
digest
pmei
bamhi
gener
pbacsarscovdedsegfp
fig
infram
delet
nsp
code
region
delet
junction
region
contain
cterminu
aa
nterminu
aa
pbacsarscovdedsegfp
digest
pmli
selflig
gener
delet
nterminu
firstli
primer
pair
nt
forward
nt
revers
use
amplifi
fragment
contain
partial
sequenc
amplifi
product
clone
pgemteasi
gener
clone
nterminu
aa
delet
follow
primer
tgcggatccccacgtgttgaaaaga
nt
ataggatccacctccattgag
nt
bamhi
site
underlin
amplifi
fragment
ligat
bamhi
site
gener
clone
last
plasmid
digest
pmli
clone
back
plasmid
pbacsarscovdedsegfp
use
similar
delet
strategi
base
plasmid
core
sequenc
delet
pcr
amplif
primer
nt
nt
sali
site
underlin
new
sali
site
genet
marker
amplifi
fragment
ligat
sali
site
gener
clone
gener
plasmid
clone
back
plasmid
pbacsarscovdedsegfp
pmei
bamhi
site
gener
plasmid
purif
transfect
construct
plasmid
purifi
qiagen
largeconstruct
kit
qiagen
accord
manufactur
protocol
transfect
perform
cell
grown
confluenc
transfect
reagent
roch
accord
manufactur
instruct
transfect
cell
incub
co
h
cultur
fresh
dmem
contain
fb
co
either
observ
hpt
use
antivir
drug
test
mgml
ribavirin
sigma
mgml
sigma
western
blot
analysi
cell
lysat
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
protein
transfer
onto
immobilonp
transfer
membran
milipor
semidri
electrophoresi
transfer
biorad
membran
block
overnight
tb
nacl
mm
trishcl
ph
wv
bsa
biosharp
probe
rabbit
polyclon
antiserum
sarscov
n
protein
produc
australian
anim
health
laboratori
gfp
beyotim
china
dilut
immunoreact
enhanc
solut
toyobo
h
follow
wash
tbst
tween
trisbuff
salin
three
time
incub
alkalin
phosphataseconjug
goat
antirabbit
immunoglobulin
dilut
immunoreact
enhanc
solut
ii
toyobo
h
signal
develop
bcipnbt
substrat
mix
sinoamerican
quantit
realtim
pcr
analys
total
cellular
rna
transfect
cell
extract
rnaprep
cell
kit
tiangen
hpt
rnase
free
dnase
promega
use
digest
dna
min
follow
incub
min
revers
transcript
perform
volum
conduct
min
follow
heat
min
primer
use
rt
quantit
pcr
follow
qsarsnf
qsarsnr
n
gene
detect
qbactinf
qbactinr
cc
bactin
detect
realtim
quantit
pcr
assay
conduct
dnaengin
opticon
machin
mj
sybr
green
realtim
pcr
master
mix
toyobo
mix
forward
revers
primer
lm
final
pcr
mixtur
thermal
cycl
condit
follow
cycl
min
follow
cycl
fluoresc
measur
cycl
melt
curv
gener
last
extens
step
experi
repeat
three
time
data
repres
mean
triplic
describ
materi
method
egfp
gene
insert
replac
gene
previous
publish
construct
rsarscovd
gener
noninfecti
replicon
plasmid
pbacsarscovdedsegfp
fig
construct
none
transcript
regul
signal
trss
sarscov
interrupt
orf
kept
intact
except
e
gene
egfp
gene
clone
control
gene
tr
retain
sequenc
gene
end
nt
respect
expect
replicon
express
sarscov
orf
level
origin
infecti
cdna
clone
result
bac
clone
stabli
propag
escherichia
coli
cell
purifi
pbacsarscovdedsegfp
transfect
cell
egfp
express
observ
h
posttransfect
fig
left
panel
indic
protein
could
express
gene
tr
western
blot
confirm
express
egfp
n
protein
fig
result
demonstr
pbacsarscovdedsegfp
replicon
could
replic
transcrib
cell
explor
feasibl
use
replicon
system
tool
drug
screen
inhibit
assay
two
known
antivir
drug
ribavirin
conduct
h
posttransfect
result
show
signific
reduct
fluoresc
cell
h
treatment
mgml
fig
right
panel
howev
cell
treat
ribavirin
wide
use
broadspectrum
replicas
inhibitor
obviou
effect
fluoresc
signal
compar
untreat
cell
fig
middl
panel
worth
note
obviou
cytotox
effect
observ
either
ribavirin
concentr
use
studi
quantit
realtim
rtpcr
use
evalu
inhibit
sarscov
n
gene
messeng
rna
product
n
gene
copi
number
reduc
logarithm
unit
treatment
mgml
fig
indic
effici
inhibit
sarscov
replic
contrast
mrna
level
hous
keep
gene
treat
untreat
cell
remain
similar
level
fluoresc
intens
detect
microscop
show
signific
differ
control
ribavirin
treat
cell
realtim
rtpcr
reveal
ribavirin
might
small
invis
inhibitori
effect
sarscov
replic
function
analysi
sarscov
sarscov
polyprotein
process
nonstructur
protein
form
replicationtranscript
complex
viral
life
circl
previou
studi
report
requir
viru
replic
studi
construct
three
recombin
variant
test
whether
conclus
could
obtain
use
new
replicon
system
first
one
delet
junction
domain
gene
second
one
delet
within
nterminu
third
delet
see
materi
method
result
present
fig
indic
fluoresc
intens
chang
first
two
delet
construct
compar
origin
replicon
sharp
reduct
third
construct
delet
confirm
realtim
rtpcr
evalu
n
gene
transcript
reveal
reduct
close
log
fig
studi
noninfecti
sarscov
replicon
gener
base
sarscovd
bac
clone
replicon
retain
sarscov
gene
except
e
gene
insert
egfp
gene
render
conveni
monitor
viru
replic
measur
fluoresc
intens
delet
gene
allow
manipul
replicon
convent
laboratori
instead
use
facil
result
indic
replicon
could
transcrib
express
heterogen
gene
vitro
use
antivir
drug
screen
analysi
viral
protein
function
moreov
newli
construct
replicon
stabl
bac
system
easili
amplifi
e
coli
manipul
revers
genet
indic
result
possibl
insert
mutat
replicon
gene
function
analysi
ribavirin
wide
use
viral
replicas
inhibitor
includ
sarscov
howev
result
show
ribavirin
effect
inhibitor
sarscov
replic
noncytotox
concentr
least
cell
line
use
studi
observ
agreement
previou
publish
studi
contrast
found
quit
effect
sarscov
infect
consist
previou
studi
base
live
virus
bat
identifi
natur
reservoir
slcov
bat
slcov
sarscov
high
similar
genom
organ
gene
gene
product
sequenc
particularli
replicas
protein
amino
acid
ident
suggest
function
replicas
protein
conserv
among
differ
sar
sarslik
cov
even
though
pathogenesi
bat
slcov
human
unknown
high
potenti
relat
cov
bat
origin
infect
caus
diseas
human
regard
import
stress
replicon
system
use
screen
drug
equal
effect
sarscov
un
known
close
relat
bat
cov
could
potenti
emerg
futur
